journal article·2025

Defect engineering in cobalt-doped prussian blue to enhance sonocatalytic activities for anticancer treatment

Jisen Guan, Rongrong Mu, Yajie Ma, Huiming Lin

Journal of Materials Chemistry B· Volume 13· Issue 39
Publisher page

Abstract

The effect of sonocatalysis on anticancer treatment is always restricted by rapid recombination of charge and low utilization of the ultrasonic cavitation effect. Herein, cobalt-doped prussian blue (PB) nanocubes were synthesized, and then they were etched by acidic solution to obtain amorphous Co-FePB@1h with abundant defects including: Fe/Co defects, Fe-(CN)6 vacancies, and dangling bonds. Both doping and defect engineering contribute to decreasing the band gap and promoting charge separation. Additionally, these strategies can regulate the band level to increase the potential of the conduction band (CB), promoting the thermodynamic feasibility and production (6-times) of reactive oxygen species (ROS). Simultaneously, US-generated holes can also oxidize endogenous glucose and nicotinamide adenine dinucleotide phosphate (NADPH), which not only further inhibit electron-hole recombination but can also depress energy supply and reductive stress, facilitating anticancer treatment. Moreover, the defect engineering can not only bring extra porous structure to enhance the ultrasonic cavitation effect but can also increase active sites to improve peroxidase (POD) activity for chemodynamic therapy (CDT). The intracellular sonocatalysis associated with nanozyme activity exhibits a notable anticancer effect. These treatments can promote immungenic cell death (ICD), thereby stimulating anticancer immune activation to combat metastasis and recurrence. With the various constituents/structures and regulatable defects, PB nanomaterials possess great potential as sonosensitizers directly for achieving great performance in sonocatalysis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Photocatalysis Techniques · Bone Tissue Engineering Materials · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Photochemical Biomaterials and Energy Storage Materials, College of Chemistry and Chemical Engineering, Harbin Normal University, Harbin 150025, China

Laboratory for Photon and Electronic Bandgap Materials, Ministry of Education, Harbin Normal University, Harbin 150025, China

Funding

National Natural Science Foundation of China · Harbin Normal University

References (43)

Show source-provided references
1. Yang · Wiley Interdiscip Rev Nanomed Nanobiotechnol. · 2024 · 16 · 198510.1002/wnan.1985 ↗
2. Xiao · Chem. Eng. J. · 2022 · 449 · 13788910.1016/j.cej.2022.137889 ↗
3. Hong · Biomaterials · 2025 · 312 · 12270910.1016/j.biomaterials.2024.122709 ↗
4. Zhang · Adv. Mater. · 2023 · 35 · 03059
5. Hu · Chem. Eng. J. · 2024 · 481 · 14845510.1016/j.cej.2023.148455 ↗
6. Ren · Coord. Chem. Rev. · 2024 · 510 · 21583310.1016/j.ccr.2024.215833 ↗
7. Meng · ACS Catal. · 2021 · 12 · 8910.1021/acscatal.1c04415 ↗
8. Peighambardoust · ACS Mater. Au · 2023 · 4 · 21410.1021/acsmaterialsau.3c00090 ↗
9. Wu · Sep. Purif. Technol. · 2023 · 311 · 12323010.1016/j.seppur.2023.123230 ↗
10. Xu · Adv. Sci. · 2024 · 11 · 06842
11. Lu · J. Mater. Chem. B · 2023 · 11 · 527210.1039/D2TB02617A ↗
12. Dacarro · Molecules · 2018 · 23 · 141410.3390/molecules23061414 ↗
13. Wang · J. Controlled Release · 2022 · 351 · 75210.1016/j.jconrel.2022.10.007 ↗
14. Wu · Small · 2024 · 20 · e230943910.1002/smll.202309439 ↗
15. Li · J. Mater. Chem. B · 2014 · 2 · 368610.1039/C4TB00516C ↗
16. Tian · Adv. Funct. Mater. · 2023 · 33 · 230081810.1002/adfm.202300818 ↗
17. Wang · Coord. Chem. Rev. · 2020 · 419 · 21339310.1016/j.ccr.2020.213393 ↗
18. Qian · Biomaterials · 2017 · 142 · 1310.1016/j.biomaterials.2017.07.016 ↗
19. Tao · Chem. Eng. J. · 2025 · 519 · 16553010.1016/j.cej.2025.165530 ↗
20. Zhu · Adv. Funct. Mater. · 202510.1002/adfm.202509057 ↗
21. Singh · Coord. Chem. Rev. · 2025 · 523 · 21628810.1016/j.ccr.2024.216288 ↗
22. Nai · Adv. Mater. · 2018 · 31 · 06825
23. Zhang · Adv. Sci. · 2023 · 10 · 02301
24. Shi · ACS Catal. · 2019 · 9 · 973910.1021/acscatal.9b03246 ↗
25. Zhang · Angew. Chem., Int. Ed. · 2023 · 62 · 03953
26. Ishizaki · Dalton Trans. · 2013 · 42 · 1604910.1039/c3dt51637g ↗
27. Shan · Cell Rep. Phys. Sci. · 2023 · 4 · 10130110.1016/j.xcrp.2023.101301 ↗
28. Han · ACS Appl. Nano Mater. · 2023 · 6 · 2233310.1021/acsanm.3c04555 ↗
29. Silva · ACS Appl. Electron. Mater. · 2020 · 2 · 92710.1021/acsaelm.9b00854 ↗
30. Zhou · Adv. Funct. Mater. · 2024 · 34 · 231401210.1002/adfm.202314012 ↗
31. Yi · Environ. Sci. Technol. · 2019 · 53 · 972510.1021/acs.est.9b01676 ↗
32. Kavan · Catal. Today · 2019 · 328 · 5010.1016/j.cattod.2018.10.065 ↗
33. Kusmierek · Catalysts · 2020 · 10 · 43910.3390/catal10040439 ↗
34. Liu · Chin. J. Catal. · 2024 · 61 · 3710.1016/S1872-2067(24)60028-8 ↗
35. Wang · Chem. Eng. J. · 2023 · 456 · 14099310.1016/j.cej.2022.140993 ↗
36. Burns · Int. J. Mol. Sci. · 2017 · 18 · 275510.3390/ijms18122755 ↗
37. Liu · Chem. Eng. J. · 2021 · 425 · 13061510.1016/j.cej.2021.130615 ↗
38. Ju · Signal Transduction Targeted Ther. · 2020 · 5 · 23110.1038/s41392-020-00326-0 ↗
39. Han · Adv. Healthcare Mater. · 2024 · 13 · 03309
40. Memari · J. Controlled Release · 2023 · 358 · 33310.1016/j.jconrel.2023.05.004 ↗
41. Gao · Int. J. Mol. Sci. · 2024 · 25 · 77110.3390/ijms25020771 ↗
42. Carroll · Immunity · 2024 · 57 · 63210.1016/j.immuni.2024.03.014 ↗
43. Fridman · Immunity · 2023 · 56 · 225410.1016/j.immuni.2023.08.009 ↗